Statistical significant heterogeneity among studies was observed in the association analysis between the MDM2 SNP309 polymorphism and endometrial cancer risk in the overall populations (GG vs. GT + TT: PQ < 0.001; Table 2). The gene discussed is MDM2; the disease is endometrial cancer.